Mangalam Drugs and Organics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.83

15.83

15.83

15.83

15.83

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

136.13

134.73

115.13

88.11

79.83

Loan funds

Secured loans

68.33

72.20

58.06

46.03

59.11

Unsecured loans

-

-

-

-

-

Total

220.29

222.76

189.02

149.97

154.77

Uses of funds

Fixed assets

Gross block

232.69

216.67

193.54

168.31

163.08

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

90.33

81.71

75.55

67.24

59.59

Net block

142.36

134.96

117.99

101.07

103.49

Capital work-in-progress

9.49

5.71

6.35

1.24

0.20

Investments

-

-

0.22

0.22

0.24

Net current assets

Current assets, loans & advances

207.77

187.75

138.28

128.13

107.42

Less : current liabilities & provisions

139.34

105.67

73.83

80.69

56.58

Total net current assets

68.43

82.09

64.45

47.44

50.84

Miscellaneous expenses not written

-

-

-

-

-

Total

220.29

222.76

189.02

149.97

154.77

Notes:

Book value of unquoted investments

-

-

0.11

0.11

0.12

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

26.33

6.26

9.61

7.28

6.77

Number of equity sharesoutstanding (Lacs)

158.28

158.28

158.28

158.28

158.28